The association of −330 interleukin‐2 gene polymorphism and HLA ‐ DR 15 allele in I ranian patients with multiple sclerosis
International Journal of Immunogenetics · 2014-08 · 41 (4) · 330-334
DOI: 10.1111/iji.12132 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Immunogenetics, online erschienen am 12.06.2014. Verfasst von A Sayad. Beteiligte Einrichtung: Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Polymorphism, Genetic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
The purpose of this case–control study was to evaluate the frequencies and potential genetic susceptibility of the −330 IL 2 T and G alleles and HLA ‐ DRB 1*1501 allele in Iranian patients with multiple sclerosis ( MS ) compared to healthy controls. Two hundred and sixty Iranian patients with MS from medical genetics department of Sarem Women hospital were selected. Besides, 450 ethnically age‐ and sex‐matched healthy individuals without personal or family backgrounds of autoimmune disorders were enrolled as a control group. All polymorphisms were analysed using RFLP ‐ PCR technique. HLA ‐ DRB 1 genotyping was carried out by HISTO TYPE SSP high‐resolution Kits according to the manufacturer's suggestions. The frequency of the T allele at the −330 IL 2 polymorphism was significantly higher in patients with MS than controls ( OR : 2.45, 95 CI : 1.9–3, P = 4 × 10 −14 ). Moreover, the T/T genotype was more frequent in patients than in controls (51% vs. 30%). This study indicated that the −330 T IL 2 allele and the T/T genotype were related to increased plasma concentration of IL 2 and a higher risk of developing MS among Iranian patients. Carrying both the −330 T IL 2 and the HLA , DRB 1* 1501 alleles showed the most susceptibly effect to MS . Our data demonstrated −330 T IL 2 allele provided major susceptibility to MS and HLA ‐ DRB 1* 1501 allele had an additive effect. In addition, it seems that studies with larger sample size are required to bring about more authentic results. Our findings suggest that IL 2 gene polymorphisms influence the susceptibility to MS in I ranian patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Sayad, A. (2014). The association of −330 interleukin‐2 gene polymorphism and HLA ‐ DR 15 allele in I ranian patients with multiple sclerosis. International Journal of Immunogenetics, 41(4), 330-334. https://doi.org/10.1111/iji.12132
Vancouver
Sayad A. The association of −330 interleukin‐2 gene polymorphism and HLA ‐ DR 15 allele in I ranian patients with multiple sclerosis. International Journal of Immunogenetics. 2014;41(4):330-334. doi:10.1111/iji.12132
BibTeX
@article{Sayad2014,
author = {Sayad, A},
title = {The association of −330 interleukin‐2 gene polymorphism and HLA ‐ DR 15 allele in I ranian patients with multiple sclerosis},
journal = {International Journal of Immunogenetics},
year = {2014},
volume = {41},
number = {4},
pages = {330--334},
doi = {10.1111/iji.12132}
}
EUVIMED